To consider whether consensus exists in recommendations for managing bipolar mixed states published in recent reviews and treatment guidelines, and to summarise what might be their best management.
Conclusion:
Limitations to and changes in the definition of mixed states compromise diagnosis and management. The striking comparison between DSM-IV and DSM-5 criteria sets risks under-diagnosis and over-diagnosis. Current reviews and guidelines offer limited evidence to guide treatment; however, management should involve addressing the contribution of any antidepressant medication, and the introduction of a second-generation antipsychotic medication to stabilise the condition.
GoodwinFKJamisonKR. Manic-depressive illness: bipolar disorders and recurrent depression. Oxford: Oxford University Press; 2007
2.
GrunzeHVietaEGoodwinGMet al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. World J Biol Psychiatry2018; 19: 2–58.
3.
MalhiGSBerkMMorrisGet al. Mixed mood: The not so united states?B disord2017; 19: 242–245.
4.
VietaEValentíM. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord2013; 148: 28–36.
5.
RosenblatJDMcIntyreRS. Treatment of mixed features in bipolar disorder. CNS Spectrums2017; 22: 141–146.
6.
CuomoANikolovaVLYalinNet al. Pharmacological treatment of mixed states. CNS spectrums2017; 22:186–195.
7.
TakeshimaM. Treating mixed mania/hypomania: a review and synthesis of the evidence. CNS Spectrums2017; 22: 177–185.
8.
YathamLNKennedySHParikhSVet al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord2018; 20: 97–170.
